Deutsche Bank
NERV icon

Deutsche Bank’s Minerva Neurosciences NERV Stock Holding History

Deutsche Bank’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,500
Closed -$6.03K – 3699
2025
Q4 		$6.03K Buy
+1,500
New +$5.57K ﹤0.01% 3560
2021
Q3 		– Sell
-14,315
Closed -$266K – 4581
2021
Q2 		$266K Buy
14,315
+2,035
+17% +$43.8K ﹤0.01% 3620
2021
Q1 		$287K Buy
12,280
+6,788
+124% +$170K ﹤0.01% 3437
2020
Q4 		$103K Sell
5,492
-2,779
-34% -$70K ﹤0.01% 3835
2020
Q3 		$211K Buy
8,271
+6,244
+308% +$169K ﹤0.01% 3186
2020
Q2 		$58K Sell
2,027
-18,068
-90% -$1.06M ﹤0.01% 3738
2020
Q1 		$967K Buy
20,095
+18,778
+1,426% +$1.13M ﹤0.01% 2106
2019
Q4 		$74K Buy
1,317
+296
+29% +$13.1K ﹤0.01% 3736
2019
Q3 		$62K Sell
1,021
-1,640
-62% -$92.9K ﹤0.01% 3815
2019
Q2 		$119K Sell
2,661
-1,801
-40% -$90.1K ﹤0.01% 4120
2019
Q1 		$278K Sell
4,462
-2,026
-31% -$122K ﹤0.01% 3805
2018
Q4 		$349K Sell
6,488
-2,901
-31% -$212K ﹤0.01% 3554
2018
Q3 		$942K Buy
9,389
+533
+6% +$40.1K ﹤0.01% 3373
2018
Q2 		$585K Buy
8,856
+3,734
+73% +$227K ﹤0.01% 3762
2018
Q1 		$255K Sell
5,122
-3,437
-40% -$165K ﹤0.01% 4069
2017
Q4 		$413K Sell
8,559
-815
-9% -$40.4K ﹤0.01% 3707
2017
Q3 		$568K Buy
9,374
+5,399
+136% +$310K ﹤0.01% 3360
2017
Q2 		$280K Buy
3,975
+1,011
+34% +$65.4K ﹤0.01% 3753
2017
Q1 		$191K Buy
2,964
+1,489
+101% +$116K ﹤0.01% 3618
2016
Q4 		$138K Buy
1,475
+1,077
+271% +$110K ﹤0.01% 3899
2016
Q3 		$44K Buy
398
+85
+27% +$8.25K ﹤0.01% 4260
2016
Q2 		$24K Sell
313
-956
-75% -$60.8K ﹤0.01% 4703
2016
Q1 		$62K Buy
+1,269
New +$54.2K ﹤0.01% 4243
2015
Q3 		– Sell
-25
Closed -$1K – 5287
2015
Q2 		$1K Buy
+25
New +$1.07K ﹤0.01% 5276

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Deutsche Bank's NERV Position: Q1 2026 in Review

Deutsche Bank sold out of Minerva Neurosciences (NERV) in Q1 2026, closing a stake of 1,500 shares — an estimated $6.03K sold.

Deutsche Bank first reported a position in NERV in Q2 2015 and held it in 24 quarters. The position peaked at $967K in Q1 2020. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Deutsche Bank reported no remaining Minerva Neurosciences position as of Q1 2026 after selling out during the quarter.
  • Deutsche Bank sold 1,500 Minerva Neurosciences shares in Q1 2026, an estimated $6.03K.
  • Deutsche Bank first reported a position in Minerva Neurosciences in Q2 2015 and held it in 24 quarters.
  • Deutsche Bank's Minerva Neurosciences position peaked at $967K in Q1 2020.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.